drug discovery
PulseAugur coverage of drug discovery — every cluster mentioning drug discovery across labs, papers, and developer communities, ranked by signal.
3 day(s) with sentiment data
-
AI's potential in drug discovery hinges on leveraging its unique strengths
Artificial intelligence holds the potential to significantly advance drug discovery and development, but its impact will be maximized by focusing on its unique capabilities. By leveraging AI's strengths, the field can o…
-
ProbeMatchDTI enhances AI drug discovery by capturing weak biochemical signals
Researchers have developed ProbeMatchDTI, a novel framework designed to improve drug-target interaction (DTI) prediction in AI-driven drug discovery. This method addresses limitations in existing approaches that tend to…
-
New MMAI Gym trains Liquid Foundation Models for drug discovery
Researchers have developed the MMAI Gym for Science, a new platform designed to train foundation models specifically for drug discovery tasks. This gym provides curated molecular data, task-specific reasoning, and bench…
-
AI streamlines 3D printing of critical aerospace alloy
Researchers at Washington State University have developed an AI-driven method to efficiently 3D print the high-performance metal alloy GRCop-42. This alloy, crucial for aerospace applications due to its heat resistance …
-
MolLedger: New GNN Improves Drug Discovery Interpretability
Researchers have developed MolLedger, a novel graph neural network architecture designed to improve the interpretability of predictions in small molecule drug discovery. This model provides built-in, per-atom attributio…
-
AI's next frontier: Data-efficient learning beyond Scaling Laws
A researcher from BIMSA, Wang Yaqing, argues that the Scaling Law paradigm in AI is hitting its limits due to data scarcity and high computational costs. She proposes "Data-Efficient Agentic Learning" (DEAL) as the next…
-
AI framework enhances drug discovery with reliable molecular property predictions
Researchers have developed a new conformal prediction framework designed to improve the reliability of AI in drug discovery, particularly when dealing with label shift. This method generates statistically rigorous predi…
-
AI in Drug Discovery: Progress, Challenges, and Future Outlook · 4 sources tracked
Multiple sources discuss the current state and future trajectory of artificial intelligence in drug discovery. While AI has shown promise in accelerating the identification and development of new medicines, its real-wor…
-
AI revolutionizes drug discovery with advanced tools and partnerships
Artificial intelligence is making significant strides in drug discovery, with tools like Google DeepMind's AlphaFold accelerating the process of understanding protein structures. Companies such as Insilico Medicine, Ben…
-
AI agents aim to simplify AlphaFold for broader access
A new approach aims to make the complex protein structure prediction tool AlphaFold more accessible. By integrating AI agents with models like Gemini and Claude, the project seeks to transform the extensive protein stru…
-
Generative AI advances inorganic compound design, review finds
A review paper published on arXiv analyzes the application of generative AI in the inverse design of inorganic compounds. While generative AI has advanced organic chemistry and drug discovery, its use in inorganic chemi…
-
New ML framework enhances drug discovery screening metrics
Researchers have developed a new machine learning framework to improve performance metric estimation in high-throughput screening (HTS) assays, which are crucial for early-stage drug discovery. The framework addresses t…
-
GFlowNet interpretability study questions learned chemistry in drug discovery models
A new study published on arXiv investigates the interpretability of GFlowNets, a type of AI model used for drug discovery. Researchers developed a framework to analyze SynFlowNet, a GFlowNet trained on drug-likeness, an…
-
New Foundation Model Accelerates Drug Discovery with Accurate ADMET Prediction
Researchers have developed MEGA-CL, a novel foundation model designed to predict the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of small molecules. This graph neural network framewo…
-
New Bayesian Optimization Method RAMBO Tackles Multi-Regime Search Spaces
Researchers have developed a new Bayesian Optimization (BO) method called RAMBO, designed to handle multi-regime search spaces more effectively than standard BO. RAMBO utilizes a Dirichlet Process Mixture of Gaussian Pr…
-
New method injects biokinetic knowledge into neural networks for data-scarce bioprocess modeling
Researchers have developed a novel approach to address data scarcity in bioprocess modeling for drug discovery and biomanufacturing. Their work systematically explores methods for integrating existing biokinetic knowled…
-
Meta AI models power Genesis Mission projects at Lawrence Berkeley Lab
Meta's AI models, including the Segment Anything Model and those built on PyTorch, are being utilized in the initial projects of the Genesis Mission at Lawrence Berkeley National Laboratory. These projects focus on area…
-
Lila Sciences builds AI-powered automated lab for scientific discovery
Lila Sciences is building an automated laboratory designed to function as an AI data center, generating vast amounts of experimentally validated scientific data. Their vision is to create a scientific superintelligence …
-
OpenAI Researcher Eyes $2B Valuation for AI Drug Discovery Startup
Miles Wang, a researcher from OpenAI, is reportedly in discussions to launch a new startup focused on AI-driven drug discovery. The venture is aiming to secure approximately $200 million in funding at a valuation of $2 …
-
AI accelerates drug discovery timelines with protein folding and simulation
Artificial intelligence is significantly speeding up drug discovery by leveraging protein folding and advanced chemical simulations. This technology is reducing the time it takes to identify potential drug candidates, e…